Altimmune
Price & Volume
Stats
See more52W Range | $2.90-$7.73 |
Market Cap | $539.7M |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $20,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$67.7M |
Diluted EPS | -$1.07 |
News
See moreYahoo Finance • 26 days ago
Obesity stocks slump on Novo's underwhelming 2026 sales forecast
Yahoo Finance • 27 days ago
Altimmune, Inc. (ALT) Gains Analyst Support Ahead of Phase 3 MASH Development
Yahoo Finance • 2 months ago
Altimmune posts mid-stage trial data showing antifibrotic activity of lead asset in MASH
Yahoo Finance • 2 months ago
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial
About
CEO | Mr. Jerome Benedict Durso |
Address | 910 Clopper Road, Gaithersburg, MD, United States, 20878 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
